Physician

Adam J. Gadzinski, M.D.

According to 2025 Medicare claims, Adam Gadzinski, M.D. (NPI: 1659613396) practices urology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is MICHIGAN HEALTHCARE PROFESSIONALS PC (NPI: 1295023547; TIN: 451674932) and primary practice location at 48073-0996. Gadzinski is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Gadzinski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 445 traditional Medicare patients, billed 6,044 HCPCS/CPT codes, and received $301,790 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 968 prescription claims across 297 beneficiaries totaling $615,659 in drug costs, led by Nubeqa (Darolutamide). DME data shows 98 claims. Open Payments data shows 72 records totaling $272,717. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,767 to $301,790. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,910 to $615,659. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$151K$302K2019 Medicare payment: $5,767 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $17,683 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $14,402 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $134,647 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $164,054 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $301,790 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20193170$5,767
202085190$17,683
202164140$14,402
20223412,313$134,647
20233884,246$164,054
20244456,044$301,790

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$308K$616K2015 Drug cost: $2,910 (USD; Tot_Drug_Cst)2016 Drug cost: $1,496 (USD; Tot_Drug_Cst)2017 Drug cost: $597 (USD; Tot_Drug_Cst)2019 Drug cost: $1,526 (USD; Tot_Drug_Cst)2020 Drug cost: $3,180 (USD; Tot_Drug_Cst)2021 Drug cost: $10,246 (USD; Tot_Drug_Cst)2022 Drug cost: $73,274 (USD; Tot_Drug_Cst)2023 Drug cost: $372,068 (USD; Tot_Drug_Cst)2024 Drug cost: $615,659 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201579152$2,910
20163579$1,496
20171415$597
2018N/RN/RN/R
20192852$1,526
20203785$3,180
202190203$10,246
2022204537$73,274
2023292976$372,068
2024297968$615,659

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.1K$8.2K2023 Medicare payment: $4,487 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $8,249 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R30$4,487
2024N/R98$8,249

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
52000Diagnostic exam of bladder and urethra using an endoscope6078$174
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more201339$95
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more126160$67
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's191303$13
81003Automated urinalysis test185315$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
NubeqaDarolutamide23690$288,246
XtandiEnzalutamide11330$158,935
Abiraterone AcetateAbiraterone Acetate361,080$66,035
OrgovyxRelugolix16480$40,103
GemtesaVibegron461,714$26,361

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachNN/R14$3,928
A4407Ostomy skin barrier, with flange (solid, flexible, or accordion), extended wear, with built-in convexity, 4 x 4 inches or smaller, eachNN/R13$1,767
A4385Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, eachNN/R12$1,161
A4432Ostomy pouch, urinary; for use on barrier with non-locking flange, with faucet-type tap with valve (2 piece), eachNN/R12$761
A4357Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, eachNN/R19$340

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.62$7,795UROGEN PHARMA, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.10$264,922AstraZeneca Pharmaceuticals LP
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam J. Gadzinski, M.D.?

Tedicare shows public-source Medicare data for Adam J. Gadzinski, M.D. (NPI 1659613396), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam J. Gadzinski, M.D. have ACO affiliation data?

Adam J. Gadzinski, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to Adam J. Gadzinski, M.D.?

Adam J. Gadzinski, M.D. is linked to MICHIGAN HEALTHCARE PROFESSIONALS PC (billing NPI 1295023547) in the available physician profile data.

Does Adam J. Gadzinski, M.D. have Open Payments data?

Adam J. Gadzinski, M.D. has 72 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.